Talis Biomedical Corporation Restricted Cash, Current
Talis Biomedical Corporation had Restricted Cash, Current of $0 as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2024-08-19
- 2024-06-30: Restricted Cash, Current $0.00.
- 2024-03-31: Restricted Cash, Current $0.00.
- 2023-06-30: Restricted Cash, Current $1.01M.
- 2023-03-31: Restricted Cash, Current $1.01M.
| Period end | Restricted Cash, Current |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-06-30 | $1.01M 10-Q · filed 2024-08-19 |
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-10 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2021-06-30 | $34.65M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $34.65M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $34.65M 10-K · filed 2022-03-15 |
| 2020-09-30 | $34.65M 10-Q · filed 2021-11-16 |